Bellevue Group AG decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 26.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,298 shares of the company's stock after selling 7,926 shares during the period. Bellevue Group AG's holdings in Cardinal Health were worth $2,637,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CAH. Aptus Capital Advisors LLC increased its position in shares of Cardinal Health by 97.8% during the fourth quarter. Aptus Capital Advisors LLC now owns 3,796 shares of the company's stock worth $449,000 after acquiring an additional 1,877 shares during the last quarter. AXA S.A. increased its holdings in Cardinal Health by 47.8% during the 4th quarter. AXA S.A. now owns 535,739 shares of the company's stock worth $63,362,000 after purchasing an additional 173,250 shares during the last quarter. Wahed Invest LLC raised its position in shares of Cardinal Health by 6.4% in the 4th quarter. Wahed Invest LLC now owns 6,292 shares of the company's stock valued at $741,000 after purchasing an additional 378 shares in the last quarter. Itau Unibanco Holding S.A. purchased a new position in shares of Cardinal Health during the 4th quarter valued at approximately $36,000. Finally, Freestone Grove Partners LP acquired a new stake in shares of Cardinal Health during the fourth quarter worth approximately $36,709,000. Hedge funds and other institutional investors own 87.17% of the company's stock.
Analyst Ratings Changes
CAH has been the subject of several recent analyst reports. Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. boosted their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Wells Fargo & Company increased their target price on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Bank of America boosted their price target on Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a report on Friday, April 11th. Finally, Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Cardinal Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $146.43.
Get Our Latest Research Report on Cardinal Health
Cardinal Health Trading Down 0.1 %
Cardinal Health stock traded down $0.19 during midday trading on Tuesday, reaching $151.80. 2,056,713 shares of the stock traded hands, compared to its average volume of 2,196,065. The firm has a fifty day moving average price of $133.36 and a two-hundred day moving average price of $125.62. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $154.10. The firm has a market cap of $36.23 billion, a price-to-earnings ratio of 28.32, a PEG ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. During the same period in the previous year, the firm posted $2.08 earnings per share. The business's revenue was up .0% on a year-over-year basis. Analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.35%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date is Tuesday, July 1st. Cardinal Health's dividend payout ratio (DPR) is 31.51%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.